IFNA1 and neoplasm: Notably, evidence indicates that AZA exerts its effects in an IFN-dependent manner by activating type I and III IFN signaling in tumor cell lines (60, 61), as well as upregulating the expression of ISGs, all of which aid in the rejuvenation of antitumor immunity (60).